Search results
Found 30091 matches for
The three year funding will provide evidence on how musculoskeletal conditions progress and their effect on people’s well-being and life chances.
Find out more about
Similar stories
TCRs drive CARs
1 May 2025
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.